The role of dynamic subtraction MRI in detection of hepatocellular carcinoma

Diagnostic and Interventional Radiology

Volumn 14, Issue 4, 2008, Pages 200-204

  Seçil, Mustafa ^a   Obuz, Funda ^a   Altay, Canan ^a   Gencel, Ömür ^a   Iǧci, Enis ^a   Saǧol, Özgül ^a   Dicle, Oǧuz ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Carcinoma; Cirrhosis; Hepatocellular; Magnetic resonance imaging

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE SUBTRACTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; COMPUTER ASSISTED DIAGNOSIS; FIBROSIS; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; STANDARD;

CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; FIBROSIS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE;

EID: 60849092929     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ward J, Robinson PJ. How to detect hepatocellular carcinoma in cirrhosis. Eur Radiol 2002; 12:2258-2272.
2. Ward J, Guthrie JA, Scott DJ, et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000; 216:154-162.
3. Brancatelli G, Federle MP, Ambrosini R, et al. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 2007; 61:57-69.
4. Efremidis SC, Hytiroglou P. The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol 2002; 12:753-764.
5. Hecht EM, Holland AE, Israel GM, et al. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 2006; 239:438-447.
6. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001; 219:445-454.
7. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N. Cirrhosis or chronic hepatitis: evaluation of small (
8. Yu JS, Kim YH, Rofsky NM. Dynamic subtraction magnetic resonance imaging of cirrhotic liver: assessment of high signal intensity lesions on nonenhanced T1-weighted images. J Comput Assist Tomogr 2005; 29:51-58.
9. Yu JS, Rofsky NM. Dynamic subtraction MR imaging of the liver: advantages and pitfalls. AJR Am J Roentgenol 2003; 180:1351-1357.
10. Bhartia B, Ward J, Guthrie JA, Robinson PJ. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 2003; 180:577-584.
11. Ito K. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. Eur J Radiol 2006;58:186-199.
12. Soyer P, Spelle L, Gouhiri MH, et al. Gadolinium chelate-enhanced subtraction spoiled gradient-recalled echo MR imaging of hepatic tumors. AJR Am J Roentgenol 1999; 172:79-82.
13. Savci G, Yazici Z, Sahin N, Akgoz S, Tuncel E. Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR Am J Roentgenol 2006; 186:130-135.
14. Karadeniz-Bilgili MY, Braga L, Birchard KR, et al. Hepatocellular carcinoma missed on gadolinium enhanced MR imaging, discovered in liver explants: retrospective evaluation. J Magn Reson Imaging 2006; 23:210-215.
15. Hashimoto M, Eto M, Akishita M, et al. Correlation between flow-mediated vasodilatation of the brachial artery and intima-media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 1999; 19:2795-2800.
16. Kwak HS, Lee JM, Kim CS. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography. Eur Radiol 2004; 14:447-457.
17. Kwak HS, Lee JM, Kim YK, Lee YH, Kim CS. Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol 2005; 15:140-147.
18. Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium-and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology 2005; 237:520-528.
19. Noguchi Y, Murakami T, Kim T, et al. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT. AJR Am J Roentgenol 2003; 180:455-460.
20. Simon G, Link TM, Wortler K, et al. Detection of hepatocellular carcinoma: comparison of Gd-DTPA-and ferumoxides-enhanced MR imaging. Eur Radiol 2005; 15:895-903.